The genetics of inflammatory bowel disease -- Environmental factors in the epidemiology of inflammatory bowel disease.-The intestinal immune system in health -- Understanding the epithelial barrier in inflammatory bowel disease.- Intestinal microbiology and ecology  in inflammatory bowel disease.- Microbial recognition and pathogen-associated molecular pattern (PAMP) receptors  in inflammatory bowel disease -- Inflammasomes  in inflammatory bowel disease.-Antimicrobial peptides  in inflammatory bowel disease -- Vascular responses to intestinal inflammation  in inflammatory bowel disease -- Immunobiology of dendritic cells in inflammatory bowel disease.-Immunobiology of T-Cells in inflammatory bowel disease -- Immunobiology of B-Cells in inflammatory bowel disease.-Immunobiology of monocytes and macrophages in inflammatory bowel disease -- Immunobiology of epithelial cells in inflammatory bowel disease -- The Th1, Th2 and Th17 paradigm in inflammatory bowel disease -- Preclinical studies using mouse models of inflammatory bowel disease.- Enhanced endoscopy in inflammatory bowel disease -- MRI in Inflammatory Bowel Disease -- CT in inflammatory bowel disease.-Ultrasound in inflammatory bowel disease.-Laboratory evaluation including novel diagnostic markers  of inflammatory bowel disease -- Histology and pathology of inflammatory bowel disease -- Activity indices based assessment of disease activity in inflammatory bowel disease.- Endoscopic assessment of disease activity and mucosal healing in inflammatory bowel disease.-Evaluation of quality of life in inflammatory bowel disease -- The natural history of inflammatory bowel disease -- Conventional medical management of Crohn's disease: sulfasalazine -- Conventional medical management of Crohn's disease: corticosteroids.-Conventional medical management of Crohn's disease: azathioprine and 6-mercaptopurine.- Conventional medical management of Crohn's Disease: Methotrexate.-Biologic Treatment of Crohn's Disease: Adalimumab -- Biologic Treatment of Crohn's Disease: Certolizumab -- Biologic Therapy of Crohn's disease: Infliximab.- Biologic Treatment of Crohn's Disease: briakinumab and ustekinumab.-Biologic Treatment of Crohn's Disease: natalizumab, vedolizumab and edrolizumab (rHUMab beta 7).-Conventional medical management of ulcerative colitis: sulfasalazine and 5-aminosalicylates.-Conventional medical management of ulcerative colitis: corticosteroids -- Conventional medical management of ulcerative colitis: azathioprinetherapy: Azathioprine.-  Conventional medical management of ulcerative colitis: cyclosporine -- Conventional medical management of ulcerative colitis: tacrolimus.- Biologic therapy of ulcerative colitis: infliximab and adalimumab -- Biologic therapy of ulcerative colitis: natalizumab, vedolizumab, edrolizumab (rHUMab beta 7) -- Probiotics, prebiotics, and antibiotics in medical management inflammatory bowel disease -- Step-Up vs. Top-Down Approach in medical management of inflammatory bowel disease -- Surgical management of Crohn's disease and ulcerative colitis -- Extraintestinal manifestations of inflammatory bowel disease: autoimmune hepatitis.-Extraintestinal manifestations of inflammatory bowel disease: primary sclerosing cholangitis (PSC) -- Extraintestinal manifestations of inflammatory bowel disease: autoimmune pancreatitis and other IgG4-related conditions.- Extraintestinal manifestations of inflammatory bowel disease: cutaneous and oral manifestations of inflammatory bowel disease -- Extraintestinal manifestations of inflammatory bowel disease:  arthritis, arthropathy and osteoporosis -- Nutrition in inflammatory bowel disease.-Fertility and pregnancy in inflammatory bowel disease -- Pediatric aspects in inflammatory bowel disease -- Management and prevention of infectious diseases in inflammatory bowel disease patients.-Diagnosis and management of colorectal neoplasia in patients with inflammatory bowel disease -- How to identify high risk patients in inflammatory bowel disease?.- Patient perspective on inflammatory bowel disease -- Patient resources in inflammatory bowel disease.